Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses
Researchers generated six human monoclonal antibodies that prevented infection.
Source: news-medical.net
Page 5 - Binding Affinity News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Binding Affinity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Binding Affinity Today - Breaking & Trending Today
New study suggests broad neutralizing antibody could provide three years of COVID protection
In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.
Source: news-medical.net
Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants
Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.
Source: news-medical.net
Research highlights the potential risk of secondary SARS-CoV-2 transmission from wild rats
In a recent study published in the journal mBio, researchers in the United States evaluated rat exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in New York City (NYC).
Source: news-medical.net
Engineering epitope scaffolds of conserved regions of SARS-CoV-2 spike
In a recent study posted to the bioRxiv* preprint server, researchers engineered epitope scaffolds (ESs) of conserved regions of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Source: news-medical.net